Regenxbio IncChange company Symbol lookupSelect an option...RGNX Regenxbio IncSGBXV Safe & Green Holdings CorpGOOG Alphabet IncWHLR Wheeler Real Estate Investment Trust IncFRHLF Freehold Royalties LtdCTNT Cheetah Net Supply Chain Service IncLASE Laser Photonics CorpGFR M3-Brigade Acquisition III CorpPCT Purecycle Technologies IncUPST Upstart Holdings IncGo
REGENXBIO Inc. is a clinical-stage biotechnology company, which is focused on providing curative potential of gene therapy. Its investigational gene therapies are designed to deliver functional genes to address genetic defects in cells. The Company’s investigational AAV Therapeutics include RGX-314, RGX-202, RGX-121, RGX-111 and RGX-181 and RGX-381. RGX-314 is meant for the treatment of large patient populations impacted by wet age-related macular degeneration (wet AMD), diabetic retinopathy and other chronic retinal diseases. RGX-202 is developed to treat Duchenne muscular dystrophy, one of the common fatal genetic disorders affecting children. RGX-121, RGX-111 and RGX-181 are developed to treat Mucopolysaccharidosis type II, Mucopolysaccharidosis type I, and late infantile neuronal ceroid lipofuscinosis type II (CLN2 disease), all of which are progressive, neurodegenerative lysosomal storage disorders. RGX-381 is developed to treat the ocular manifestations of CLN2 disease.
|
|
|
|
| |
- Prev Close
- 17.62
- Today's Open
- 17.62
- Day's Range
- 17.10-17.62
- Avg Vol (10-day)
- 378.0K
- Last (time)
- 4:00p ET 09/22/23
- Last (size)
- 20
- 52-Wk Range
16.93 - 27.20- LowHigh
- 52-Wk Range
% Above Low
The current share price compared to the 52-week low.
- 1.06%
- Historical Volatility
Historical Volatility
The volatility of a stock over a given time period. It is calculated by determining the average standard deviation from the average price of the stock over one month or 21 business days. Historical volatility can be compared with implied volatility to determine if a stock's options are over- or undervalued.
- 52.5%
- Market Cap
- 752.2M
- Shares Outstanding
- 44.0M
- EPS (TTM, GAAP)
EPS (TTM, GAAP)
GAAP EPS (TTM) refers to a company's earnings per share (EPS) for the trailing twelve-month (TTM) period. EPS is calculated by dividing the adjusted income available to common stockholders for the trailing twelve months by the trailing twelve-month diluted weighted average shares outstanding.
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
- -6.32
- P/E Ratio (TTM, GAAP)
P/E Ratio (TTM, GAAP)
GAAP P/E is a relative valuation measure used to determine if a stock is expensive in relation to its peers. It is calculated by dividing the current stock price by the sum of the Diluted Earnings Per Share from continuing operations BEFORE Extraordinary Items and Accounting Changes over the last reported 12 months.
GAAP vs. Non-GAAP Earnings
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
- --
- Annual Dividend/Yield
Annual Dividend/Yield
Annual Dividend is calculated by multiplying the announced next regular dividend amount times the annual payment frequency. If no new dividend has been announced, the most recent dividend is used. If dividend payments are inconsistent, as with many ADRs, the annual dividend is calculated by totaling the regular dividends paid over the trailing 12 months. Annual Dividend/yield calculations do not guarantee or imply future payment of dividends.
- No dividend
- Ex-dividend Date
- No dividend
- Dividend Pay Date
- No dividend
- Beta
Beta
The measure of a security's volatility in relation to the S&P 500. Beta less than 1 means the security's price or NAV has been less volatile than the market. Beta greater than 1 means the security's price or NAV has been more volatile than the market.
- 1.1
- % Held by Institutions
% Held by Institutions
Percentage of outstanding shares that are owned by institutional investors. Calculated from current quarterly filing as of today.
- 90.24
- Short Interest(% of float 08/31/23)
Short Interest
The number of shares of a security that have been sold short by investors. It is typically expressed as a percentage of the total number of shares outstanding and is reported on a monthly basis.
- 10.62
Latest News
| September 05, 2023 | |
|---|---|
| 7:05 am ET | |
| PR Newswire | |
| August 30, 2023 | |
| 7:05 am ET | |
| PR Newswire | |
| August 23, 2023 | |
| 4:05 pm ET | |
| PR Newswire | |
| August 02, 2023 | |
| 4:06 pm ET | |
| PR Newswire | |
| August 01, 2023 | |
| 4:06 pm ET | |
| PR Newswire | |
| July 26, 2023 | |
| 7:05 am ET | |
| PR Newswire | |
| July 24, 2023 | |
| 4:05 pm ET | |
| PR Newswire | |
| July 11, 2023 | |
| 7:05 am ET | |
| PR Newswire | |
| June 27, 2023 | |
| 7:05 am ET | |
| PR Newswire | |
| Go to all current & historical news | |
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
Options are not suitable for all investors as the special risks inherent to options trading may
expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.
"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.
Copyright © 2023. All rights reserved.